Compare BELFB & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFB | PBH |
|---|---|---|
| Founded | 1949 | 1996 |
| Country | United States | United States |
| Employees | 5370 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | N/A | 2004 |
| Metric | BELFB | PBH |
|---|---|---|
| Price | $199.68 | $65.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $174.25 | $80.75 |
| AVG Volume (30 Days) | 140.6K | ★ 366.0K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $28.52 | N/A |
| Revenue Next Year | $7.85 | $2.15 |
| P/E Ratio | $42.80 | ★ $23.49 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $58.00 | $57.25 |
| 52 Week High | $248.61 | $88.55 |
| Indicator | BELFB | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 39.01 | 39.92 |
| Support Level | $130.49 | $62.84 |
| Resistance Level | $248.61 | $68.51 |
| Average True Range (ATR) | 9.39 | 1.73 |
| MACD | -5.13 | -0.59 |
| Stochastic Oscillator | 25.73 | 9.10 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.